Description
Release form
Injectable solution
Packaging
5 ampoules 5 ml.
Pharmacological action of
The drug provides the liver, whose metabolic activity is impaired, with a high dose of ready-to-digest, high-energy essential phospholipids . These “essential phospholipids” are ideally combined with natural endogenous phospholipids in chemical structure. They mainly penetrate the liver cells, invading their membranes.
Essential phospholipids:
normalize liver function and liver cell enzyme activity
reduce liver energy consumption
promote liver cell regeneration
convert neutral fats and cholesterol to forms that facilitate their metabolism
stabilize the physicochemical properties of bile.
Indications
Fatty liver degeneration (including diabetes mellitus) acute and chronic hepatitis, cirrhosis of the liver, necrosis of liver cells, hepatic coma and precoma, toxic liver damage, toxicosis of pregnancy, pre- and postoperative treatment, especially during operations in the field hepatobiliary zone psoriasis radiation syndrome.
Contraindications
– Hypersensitivity to the drug.
IV solution cannot be used to treat newborns and premature babies.
Special instructions
Use only clear solution!
Composition of
5 ml of the solution contains: Active ingredient:
phosphatidylcholine from soybeans of a dried substance containing 93% (3-sn-phosphatidyl) choline: synonyms – ² Ñessential phospholipids ² Ñ, ² ÑEPL ® ² Ñ – 250 mg.
Other ingredients:
benzyl alcohol – 45 mg,
deoxycholic acid ² 115 mg,
sodium chloride – 12 mg,
sodium hydroxide – 11.5 mg,
riboflavin – 0.5 mg,
– tocopherol – 0.75 mg,
ethanol ² 16.304 mg,
water for injection – 4543, 680 mg.
Dosage and administration
The drug is intended for intravenous administration, it should not be administered intramuscularly due to possible local irritation reactions. In the absence of other doctor’s recommendations, 1-2 ampoules (5-10 ml) or in severe cases, 2-4 ampoules (10-20 ml) per day. The contents of 2 ampoules can be administered simultaneously. Do not mix in the same syringe with other drugs. It is recommended to dilute the solution with the patient’s blood in a ratio of 1: 1.
If it is necessary to dilute the drug, only 5 or 10% dextrose solution for infusion administration is used, and the solution of the diluted drug should remain transparent throughout the entire time of administration.
Do not dilute the drug with electrolyte solutions (isotonic solution, Ringer’s solution)!
It is recommended that parenteral administration be supplemented with oral administration of the drug as soon as possible.
Side effects of the
From the digestive system: when using the solution in high doses rarely – diarrhea when using capsules rarely – a feeling of discomfort in the abdomen.
Other: when using capsules rarely – allergic reactions.
Storage conditions
Store at a temperature not exceeding 8 ° C.
active substance
Phospholipids
Terms and conditions otpuska IZ drugstore
prescription
waf Dosage form
infusion solution
Sanofi-Aventis, France
